Despite engaging with more than 30 potential buyers and receiving five nonbinding offers, the company did not receive any final proposals and has decided to move forward independently, according to a press release.
The review, which began in May 2024, explored various options to maximize shareholder value, including a potential acquisition. Veradigm’s board of directors, alongside financial and legal advisers, evaluated bids from strategic partners and financial sponsors but ultimately determined that continuing as an independent entity was the best path forward.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
